about
Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndromePET imaging of leptin biodistribution and metabolism in rodents and primates.Nontelomeric role for Rap1 in regulating metabolism and protecting against obesity.Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease.Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter.Cellular program controlling the recovery of adipose tissue mass: An in vivo imaging approach.Phenotypic effects of an induced mutation of the ObRa isoform of the leptin receptor.Fuel homeostasis and locomotor behavior: role of leptin and melanocortin pathways.Site-specific (18)F-labeling of the protein hormone leptin using a general two-step ligation procedure.Weight Loss and Variation of Levothyroxine Requirements in Hypothyroid Obese Patients After Bariatric Surgery.In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity.Genetic screening for melanocortin-4 receptor mutations in a cohort of Italian obese patients: description and functional characterization of a novel mutation.Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases.Frequency of the GPR7 Tyr135Phe allelic variant in lean and obese subjects.Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric banding.Chronic Renin-Angiotensin System (RAS) Blockade May Not Induce Hypotension During Anaesthesia for Bariatric Surgery.The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF.Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype.Integrating medical and surgical therapies to optimize the outcomes of type 2 diabetes.Acquired partial lipodystrophy after bone marrow transplant during childhood: a novel syndrome to be added to the disease classification list.Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanismsSporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor geneActivating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiterActivating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiterHepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric bandingSerum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects
P50
Q28246179-B55FC5A3-CD45-4C5D-8E22-1F6EF7EF1183Q30494418-25620D6F-A2ED-4D3D-9CD0-A3A79357E39EQ33924629-129E1F81-8640-4A8D-B170-08FC204287D7Q34438152-D19C70B1-0913-47A1-AA13-08128788405EQ35578006-EFEBB65E-2EBD-4CA0-BEDA-4C0909481F88Q36853163-3F8FD886-32CE-432F-B63D-9B544A09F975Q37372848-1336D269-8DEE-4883-B9F3-430F88156E2CQ38287097-10270EF3-CE4B-448C-92AF-FF24E335A9E1Q38289868-53E3EFDE-A634-40DE-8FF3-301AAB8F5242Q39983602-4E604E94-045D-4203-AD94-9E006E2FDC79Q44753264-416F1789-FD45-4BEE-B31A-312340ED2966Q44757180-39E1076F-330C-4CDD-9491-BE4DE9A367BFQ45105899-B5CEF1FD-AE82-4306-A5D1-C899C3B53F74Q45657113-0BEC01E8-DBC6-49A6-9DF6-1249A323F7DEQ47306702-ACBC553E-F692-4A38-84D9-6DB4ED53D350Q47657571-03807FF5-017F-4F79-9A0E-99CBCCC2CDC9Q47833605-64CB3F86-6207-4570-8B98-5EE015CC9B87Q50201499-BB223358-6CEA-4E09-BBE0-6301AC485C7BQ53099676-B72C67A9-539D-4445-9067-EDAB8FF74E29Q53155762-2D206606-9913-4165-9142-026D722778A8Q73194318-D609207B-4A15-4653-A536-5B437B8695EEQ73196833-DAC2F44A-2E32-4DE7-8A27-BEEB504A5E7AQ73892802-491B0A06-2A8A-477B-9281-61B1B386D064Q77113938-72360D54-4003-4946-83AA-56CB701ECE15Q82816416-4ECA33A3-9144-4DA5-9594-EC7471B3C140Q92836306-4EA2402F-AA28-4887-89F5-861558C24EF4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanni Ceccarini
@ast
Giovanni Ceccarini
@en
Giovanni Ceccarini
@es
Giovanni Ceccarini
@nl
type
label
Giovanni Ceccarini
@ast
Giovanni Ceccarini
@en
Giovanni Ceccarini
@es
Giovanni Ceccarini
@nl
prefLabel
Giovanni Ceccarini
@ast
Giovanni Ceccarini
@en
Giovanni Ceccarini
@es
Giovanni Ceccarini
@nl
P106
P1153
6603154071
P21
P31
P496
0000-0003-0701-642X